Research should now be focused on developing safe strategies to selectively suppress or enhance immune responses regulated by HLA-G that can be applied to women with pathological pregnancy disorders, as well as patients receiving transplants or with a life-threatening tumor. The gene discussed is HLA-G; the disease is neoplasm.